Amerise Biosciences Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1984.
1984 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Amerise Biosciences Limited

Amerise Biosciences Limited, a active public limited company, was established on 27 August 1984 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: L29199GJ1984PLC007195. Registered under ROC Roc Ahmedabad. it is listed on BSE: 531681. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹6.61 Cr.

Formerly known as Amradeep Industries Limited. It upholds a compliant status. In 2023, it reported revenue of ₹87.58 K and a net worth of ₹5.52 Cr. Its leadership includes Manisha Patel Maneklal (Director), Kelash Bunkar (Director), Albert Hines (Whole-Time Director). Past directors included Nileshkumar Tribhovandas Kava, Anand Ramanlal Trivedi, Ganpat Motiram Rawal. It holds ₹3.84 M open charges and no settled loans. Its latest AGM occurred on 23 September 2025, with the balance sheet filed on 31 March 2025. It is based at 24, Laxmi Chambers, Navjeevan Press Road, Opp. Old Gujarat High Court,, Ahmedabad, Gujarat, 380014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L29199GJ1984PLC007195

  • Registration Number

    007195

  • Incorporation Date

    27 August 1984

  • Authorized Capital

    ₹7.50 Cr

  • Paid-Up Capital

    ₹6.61 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 531681)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 Cr
  • Paid Up Capital ₹ 6.61 Cr
  • Company Age 41 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.84 M
  • Revenue Growth **** -99.91%
  • Profit Growth **** -121.65%
  • Ebitda **** -529.61%
  • Net Worth -2.11%
  • Total Assets -52.89%
Company report

Amerise Biosciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Amerise Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Amerise Biosciences Limited?
Current Directors
Name Designation Appointment Date Status
Manisha Patel Maneklal Director 24 Jun 2019 Current
Kelash Bunkar Director 03 Feb 2025 Current
Albert Hines Whole-Time Director 02 Feb 2026 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Aug 2014 Past
Pramod Abcsdd Director 18 Dec 2009 Past
Pramod Abcsdd Director 31 Mar 2008 Past
Pramod Abcsdd Director 19 Mar 2019 Past
Pramod Abcsdd Director 15 Jul 2009 Past
Pramod Abcsdd Additional Director 20 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Amerise Biosciences.

Amerise Biosciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.91% decrease. The company also saw a substantial fall in profitability, with a 121.65% decrease in profit. The company's net worth dipped by a decrease of 2.11%.

Amerise Biosciences revenue growth over time
Amerise Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -99.91%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -52.89%
*******
*******
*******
*******
Profit or Loss
*******
 -121.65%
*******
*******
*******
*******
Net Worth
*******
 -2.11%
*******
*******
*******
*******
EBITDA
*******
 -529.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Amerise Biosciences?

In 2022, Amerise Biosciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,839,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Gujarat State Financial Corporation : 0.29 Cr
  • Bank Of Baroda : 0.09 Cr
Latest Charge Details
Date Lender Amount Status
17 Mar 1987 Bank Of Baroda ₹0.90 M Open
20 Aug 1985 Gujarat State Financial Corporation ₹2.94 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Amerise Biosciences?

Unlock and access historical data on people associated with Amerise Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Amerise Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amerise Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Amerise Biosciences
Recent Activity within the Organization
  • Director Appointment

    Progress on Albert Hines was appointed as a Cfo was appointed as a Cfo on 04 Feb 2026 & has been associated with this company since 15 days . was documented.

  • Director Appointment

    Albert Hines was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 02 Feb 2026 & has been associated with this company since 17 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Amerise Biosciences Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Amerise Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Progress on Kelash Bunkar was appointed as a Director was appointed as a Director on 03 Feb 2025 & has been associated with this company since 1 year 16 days . was documented.

  • Director Appointment

    Minal Vinodkumar Lakhlani was appointed as a Company Secretary was appointed as a Company Secretary on 12 Nov 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Amerise Biosciences Limited?

The CIN of Amerise Biosciences Limited is L29199GJ1984PLC007195.

Where is Amerise Biosciences Limited headquartered?

Amerise Biosciences Limited is headquartered at 24, Laxmi Chambers, Navjeevan Press Road, Opp. Old Gujarat High Court,, Ahmedabad, Gujarat, 380014.

When was Amerise Biosciences Limited incorporated?

Amerise Biosciences Limited was incorporated on 27 August 1984.

Who are the current directors of Amerise Biosciences Limited?

The current directors of Amerise Biosciences Limited are

What is the primary industry of Amerise Biosciences Limited?

The primary industry of Amerise Biosciences Limited is Trade.

Is Amerise Biosciences Limited a listed company?

Amerise Biosciences Limited is listed. It is listed on BSE: 531681.

What is the capital structure of Amerise Biosciences Limited?

The authorized capital of Amerise Biosciences Limited is ₹7.50 Cr, and the paid-up capital is ₹6.61 Cr.

What is the compliance status of Amerise Biosciences Limited?

The compliance status of Amerise Biosciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available